Recalls / Active ingredient / Carfilzomib
Carfilzomib
1 FDA drug recall involving the active ingredient “Carfilzomib”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2016-12-15 | Class II | AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administr | Amgen, Inc. |